Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Fairlie

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
British Journal of Pharmacology|December 12, 2001
Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonistA J Strachan, I A Shiels, R C Reid, et al.
British Journal of Cancer|June 22, 1999
Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamateL Qiu, M J Kelso, C Hansen, et al.
International Journal for Parasitology|June 17, 2000
Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agentsK T Andrews, A Walduck, M J Kelso, et al.
Bone|December 4, 2016
Histone deacetylases (HDAC) in physiological and pathological bone remodellingM D Cantley, A C W Zannettino, P M Bartold, et al.
Mediators of Inflammation|January 1, 1993
Inhibitory effects of bisbenzylisoquinolines on synthesis of the inflammatory cytokines interleukin-1 and tumour necrosis factor-alphaW K Seow, K Nakamura, Y Sugimura, et al.
Biochemical and Biophysical Research Communications|February 1, 2000
Inhibitors of beta-amyloid formation based on the beta-secretase cleavage siteG Abbenante, D M Kovacs, D L Leung, et al.
British Journal of Pharmacology|December 21, 2013
Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory diseaseM D Hollenberg, K Mihara, D Polley, et al.
Biochemical Pharmacology|August 6, 2000
Inhibition of C5a-induced neutrophil chemotaxis and macrophage cytokine production in vitro by a new C5a receptor antagonistD R Haynes, D G Harkin, L P Bignold, et al.
Journal of Medicinal Chemistry|August 28, 1998
Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5aA K Wong, A M Finch, G K Pierens, et al.
Biochemical Pharmacology|May 30, 2001
Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptorS A Cain, T M Woodruff, S M Taylor, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
British Journal of Pharmacology|December 12, 2001
Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonistA J Strachan, I A Shiels, R C Reid, et al.
British Journal of Cancer|June 22, 1999
Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamateL Qiu, M J Kelso, C Hansen, et al.
International Journal for Parasitology|June 17, 2000
Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agentsK T Andrews, A Walduck, M J Kelso, et al.
Bone|December 4, 2016
Histone deacetylases (HDAC) in physiological and pathological bone remodellingM D Cantley, A C W Zannettino, P M Bartold, et al.
Mediators of Inflammation|January 1, 1993
Inhibitory effects of bisbenzylisoquinolines on synthesis of the inflammatory cytokines interleukin-1 and tumour necrosis factor-alphaW K Seow, K Nakamura, Y Sugimura, et al.
Biochemical and Biophysical Research Communications|February 1, 2000
Inhibitors of beta-amyloid formation based on the beta-secretase cleavage siteG Abbenante, D M Kovacs, D L Leung, et al.
British Journal of Pharmacology|December 21, 2013
Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory diseaseM D Hollenberg, K Mihara, D Polley, et al.
Biochemical Pharmacology|August 6, 2000
Inhibition of C5a-induced neutrophil chemotaxis and macrophage cytokine production in vitro by a new C5a receptor antagonistD R Haynes, D G Harkin, L P Bignold, et al.
Journal of Medicinal Chemistry|August 28, 1998
Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5aA K Wong, A M Finch, G K Pierens, et al.
Biochemical Pharmacology|May 30, 2001
Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptorS A Cain, T M Woodruff, S M Taylor, et al.
Pageof 8